Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D003556:Cystitis / Q000139:chemically induced; D004334:Drug Administration Schedule; D006801:Humans; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control
D000970:Antineoplastic Agents